• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Give Kids A Smile Program Celebrates 23rd Year of Providing Free Oral Health Care Services to Underserved Children

    2/10/25 6:30:00 AM ET
    $CL
    $HSIC
    Package Goods/Cosmetics
    Consumer Discretionary
    Medical Specialities
    Health Care
    Get the next $CL alert in real time by email

    The American Dental Association Foundation's Initiative, with Exclusive National Sponsors Henry Schein and Colgate-Palmolive, Continues to Expand Its Reach, With Nearly 325,500 Children Expected to Receive Care Throughout 2025

    The American Dental Association Foundation (ADA Foundation) is celebrating the 23rd year of its Give Kids A Smile® (GKAS) program, which officially launched on Friday, February 7, at the 2025 national kick-off event at Meharry Medical College School of Dentistry. Since its national launch in 2003, GKAS volunteers have provided free oral health education and services to more than 9.5 million underserved children in the U.S.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250207520214/en/

    A participant receives a dental exam during the 2025 national kick-off event at Meharry Medical College School of Dentistry. (Photo: Business Wire)

    A participant receives a dental exam during the 2025 national kick-off event at Meharry Medical College School of Dentistry. (Photo: Business Wire)

    In 2025, nearly 1,100 GKAS events are scheduled to take place throughout the nation, and it is estimated that approximately 325,500 underserved children will receive free oral health education, screenings, and preventive and restorative services, such as cleanings and fillings. These services will be provided by approximately 25,000 dentists and dental team members who volunteer at local GKAS events, using essential oral health care products donated by national sponsors, Henry Schein, Inc. (NASDAQ:HSIC) and Colgate-Palmolive Company (NYSE:CL), as well as Henry Schein's supplier partners.

    "The Meharry Medical College team is greatly pleased to be the launch site of this year's Give Kids A Smile national program," said James E.K. Hildreth, Ph.D., M.D., President of Meharry. "We recognize that oral health is central to physical health and part of individual well-being. Our pediatric dental team — as well as the entire Meharry School of Dentistry — embraces Give Kids A Smile as a representation of our mission of what we call ‘health caring.' That mission has been central to our college since we were founded as a medical school nearly 150 years ago, and since 1886, when dentistry became part of our educational enterprise."

    According to the U.S. Centers for Disease Control, 50 percent of children aged six to nine years have had cavities in their primary (baby) or permanent teeth. Children aged six to nine from lower-income households are more than twice as likely to have untreated cavities than children from higher-income households.

    "What started, 23 years ago, as a grassroots effort in St. Louis has grown into a nationwide movement to ensure that every child has access to quality oral health care," said Dr. Michele M. Tulak-Gorecki, Chair, ADA Foundation. "The success of GKAS is a testament to the dedication of approximately 4,500 dentists and 20,000 dental team members who volunteer annually, as well as the unwavering support of our national sponsors, Henry Schein and Colgate. Throughout its history, GKAS has brought care to more than 9.5 million children. I am grateful to everyone who has contributed to this program, dentists, dental students, and dental team members, as we all share a common purpose: to Give Kids A Smile and help children in need."

    Since the program's inception, Henry Schein has contributed more than $20 million in oral health care products in partnership with its supplier partners. Team Schein also donates thousands of volunteer hours each year preparing and sending more than 40,000 dental kits to ensure volunteers have the supplies needed to deliver much-needed oral care.

    "At the heart of Henry Schein lies a deep commitment to helping expand access to health care," said Dave Steck, President of Henry Schein's U.S. Dental Group. "GKAS exemplifies this dedication, and we are honored to join the American Dental Association and American Dental Association Foundation as an exclusive national partner. Together, we will continue championing a critical mission: enhancing access to vital oral health care for all. We extend our sincere gratitude to everyone involved in this program for their tireless efforts in creating a healthier future for our communities."

    Since 2007, Colgate-Palmolive has supported GKAS as the exclusive sponsor of essential health and hygiene products to help build proper oral hygiene habits, which reflects the Company's purpose to reimagine a healthier future for all. In addition to supporting GKAS, Colgate-Palmolive promotes health equity and optimal health and well-being among children who are underserved and their families through its Know Your OQ initiative, a free oral health resource that helps determine your oral health quotient, and its Bright Smiles, Bright Futures® initiative. Established in 1991, the initiative leads global social impact efforts that empower children and families to achieve healthy and bright futures, and has reached more than 1.7 billion children and their families in over 100 countries around the world.

    "As the worldwide leader in oral care, Colgate is deeply committed to our purpose to reimagine a healthier future for all," said Dawna Michelle Fields, Director, Community & Operations, North America, Colgate Bright Smiles, Bright Futures Program and member of the ADA's Give Kids A Smile National Advisory Committee. "Colgate-Palmolive is proud to be a long-standing supporter of the Give Kids A Smile program, as we understand the importance of promoting oral health literacy to children and their families."

    Henry Schein supplier partners that are supporting the 2025 GKAS program through product donations include Centrix, Colgate, Dash Medical Gloves, Dukal, DMG, Medicom, Premier, Sionbrands, and Solventum.

    For more information about Give Kids A Smile, visit: www.adafoundation.org/GKAS; Facebook.com/GiveKidsASmile.

    About the ADA Foundation:

    The ADA Foundation is the 501(c)3 charitable arm of the American Dental Association. The Foundation encourages hope and health in communities through philanthropy, professional development and recognizing promising leaders in the dental profession. As part of these efforts, the Foundation oversees Give Kids A Smile® and its suite of smile programs like Tiny Smiles and Give Veterans A Smile, in addition to Charitable Assistance Grants, Whiston Leadership Award, and Crest and Oral-B Promising Researcher Award. For more information about the ADA Foundation, visit www.adafoundation.org.

    About American Dental Association:

    The not-for-profit ADA is the nation's largest dental association, representing 159,000 dentist members. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. The ADA's state-of-the-art research facilities develop and test dental products and materials that have advanced the practice of dentistry and made the patient experience more positive. The ADA Seal of Acceptance long has been a valuable and respected guide to consumer dental care products. The Journal of the American Dental Association (JADA), published monthly, is the ADA's flagship publication and the best-read scientific journal in dentistry. For more information about the ADA, visit ADA.org. For more information on oral health, including prevention, care, and treatment of dental disease, visit the ADA's consumer website MouthHealthy.org.

    About Henry Schein, Inc.

    Henry Schein, Inc. (NASDAQ:HSIC) is a solutions company for health care professionals powered by a network of people and technology. With approximately 26,000 Team Schein Members worldwide, the Company's network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology, and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.

    Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our distribution centers.

    A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 33 countries and territories. The Company's sales reached $12.3 billion in 2023 and have grown at a compound annual rate of approximately 11.5 percent since Henry Schein became a public company in 1995.

    For more information, visit Henry Schein at www.henryschein.com, Facebook.com/HenrySchein, Instagram.com/HenrySchein, LinkedIn.com/Company/HenrySchein, and @HenrySchein on X.

    About Colgate-Palmolive Company:

    Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as Hill's Science Diet and Hill's Prescription Diet. We are recognized for our leadership and innovation in promoting sustainability and community wellbeing, including our achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children's oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.7 billion children and their families since 1991. For more information about Colgate's global business and how we are building a future to smile about, visit www.colgatepalmolive.com.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250207520214/en/

    Lauren DelGuidice

    Senior Corporate Media Relations Specialist

    [email protected]

    631.479.7309

    Get the next $CL alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CL
    $HSIC

    CompanyDatePrice TargetRatingAnalyst
    Colgate-Palmolive Company
    $CL
    1/13/2026$86.00Underweight → Equal Weight
    Wells Fargo
    Colgate-Palmolive Company
    $CL
    1/7/2026$88.00Neutral → Overweight
    Piper Sandler
    Colgate-Palmolive Company
    $CL
    12/11/2025Buy → Hold
    Argus
    Henry Schein Inc.
    $HSIC
    12/9/2025$86.00Overweight
    Barclays
    Colgate-Palmolive Company
    $CL
    12/9/2025$88.00Sector Perform → Outperform
    RBC Capital Mkts
    Colgate-Palmolive Company
    $CL
    10/3/2025$84.00Neutral
    Piper Sandler
    Henry Schein Inc.
    $HSIC
    8/26/2025$83.00In-line → Outperform
    Evercore ISI
    Henry Schein Inc.
    $HSIC
    7/25/2025$75.00Buy → Hold
    Stifel
    More analyst ratings

    $CL
    $HSIC
    SEC Filings

    View All

    SEC Form 8-K filed by Henry Schein Inc.

    8-K - HENRY SCHEIN INC (0001000228) (Filer)

    1/12/26 7:00:12 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form 8-K filed by Henry Schein Inc.

    8-K - HENRY SCHEIN INC (0001000228) (Filer)

    12/23/25 4:05:30 PM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement

    8-K - HENRY SCHEIN INC (0001000228) (Filer)

    12/23/25 7:00:20 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $CL
    $HSIC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.

    1/16/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer

    Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S. Henry Schein, Inc. (NASDAQ:HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115495488/en/CLIA Waived CitoCBC System Des

    1/15/26 10:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Names Frederick M. Lowery as Chief Executive Officer

    Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire

    1/12/26 7:00:00 AM ET
    $HSIC
    $TMO
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    $CL
    $HSIC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Newman Brian was granted 238 shares, increasing direct ownership by 5% to 5,313 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    1/6/26 4:07:03 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Bilbrey John P was granted 301 shares, increasing direct ownership by 0.82% to 37,195 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    1/6/26 4:07:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Norrington Lorrie M was granted 333 shares, increasing direct ownership by 0.85% to 39,648 units (SEC Form 4)

    4 - COLGATE PALMOLIVE CO (0000021665) (Issuer)

    1/6/26 4:07:01 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HSIC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Colgate-Palmolive upgraded by Wells Fargo with a new price target

    Wells Fargo upgraded Colgate-Palmolive from Underweight to Equal Weight and set a new price target of $86.00

    1/13/26 8:40:58 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive upgraded by Piper Sandler with a new price target

    Piper Sandler upgraded Colgate-Palmolive from Neutral to Overweight and set a new price target of $88.00

    1/7/26 8:42:57 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate-Palmolive downgraded by Argus

    Argus downgraded Colgate-Palmolive from Buy to Hold

    12/11/25 8:17:14 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    $CL
    $HSIC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Daniel William K bought $670,800 worth of shares (10,000 units at $67.08) (SEC Form 4)

    4 - HENRY SCHEIN INC (0001000228) (Issuer)

    8/11/25 4:26:33 PM ET
    $HSIC
    Medical Specialities
    Health Care

    $CL
    $HSIC
    Financials

    Live finance-specific insights

    View All

    Colgate-Palmolive Webcasts 2025 Fourth Quarter & Full Year Earnings Conference Call January 30, 2026 – 8:30 a.m. ET

    Colgate-Palmolive Company (NYSE:CL) will provide a live webcast of its 2025 fourth quarter and full year earnings conference call on Friday, January 30, 2026, at 8:30 a.m. ET. The call will be hosted by Chairman, President and CEO, Noel Wallace, Chief Financial Officer, Stan Sutula, and Chief Investor Relations Officer and EVP, M&A, John Faucher. Investors may access the earnings press release, prepared materials and the live audio webcast on Colgate's website at https://investor.colgatepalmolive.com/events-and-webcasts. For those unable to participate during the live webcast, a recorded version of the webcast will be made available through the Investor Center section of Colgate's website.

    1/16/26 9:30:00 AM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Colgate Declares Regular Quarterly Dividend

    The Board of Directors of Colgate-Palmolive Company (NYSE:CL) today declared a quarterly cash dividend of $0.52 per common share, payable on February 13, 2026, to shareholders of record on January 21, 2026. The Company has paid uninterrupted dividends on its common stock since 1895. * * * Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom's of Maine, EltaMD, Filorga, Irish Spring, Lady Speed

    12/10/25 4:35:00 PM ET
    $CL
    Package Goods/Cosmetics
    Consumer Discretionary

    Henry Schein Reports Record Third Quarter 2025 Financial Results and Raises Full Year Non-GAAP EPS Guidance

    Q3 2025 GAAP diluted EPS of $0.84, compared to $0.78 GAAP diluted EPS in Q3 2024, and Q3 2025 non-GAAP diluted EPS of $1.38, compared to $1.22 non-GAAP diluted EPS in Q3 2024 Raises 2025 guidance for non-GAAP diluted EPS to $4.88 to $4.96 and sales growth to 3-4% to reflect third quarter results Announces value creation initiatives expected to deliver over $200 million of operating income improvement over the next few years Agreement reached to provide KKR the right to increase its HSIC stock ownership up to 19.9% Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results

    11/4/25 6:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $CL
    $HSIC
    Leadership Updates

    Live Leadership Updates

    View All

    Henry Schein Enters Exclusive Distribution Agreement for CytoChip's CLIA-Waived Hematology Analyzer

    Partnership Expands Access to FDA-Cleared CitoCBC® System Across the U.S. Henry Schein, Inc. (NASDAQ:HSIC) has entered into a new exclusive distribution agreement with CytoChip Inc. for its flagship product, the CitoCBC® system, a U.S. Food and Drug Administration (FDA) 510(k)-cleared device. Available now to Henry Schein customers in the United States, the CitoCBC system is the first cartridge-based Complete Blood Count (CBC) system to receive a CLIA Waiver, helping expand access to accurate, lab-quality testing at the point of care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260115495488/en/CLIA Waived CitoCBC System Des

    1/15/26 10:00:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    Henry Schein Names Frederick M. Lowery as Chief Executive Officer

    Industry veteran brings more than 20 years of healthcare distribution experience and operational excellence Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of healthcare solutions to office-based dental and medical professionals, today announced the appointment of Frederick M. Lowery as its new Chief Executive Officer ("CEO"), effective March 2, 2026, at which time he will join the Board of Directors. Mr. Lowery succeeds Stanley M. Bergman, who will step down as CEO after 35 years and continue to serve as Chairman of the Board to ensure a smooth and effective leadership transition. This press release features multimedia. View the full release here: https://www.businesswire

    1/12/26 7:00:00 AM ET
    $HSIC
    $TMO
    Medical Specialities
    Health Care
    Industrial Machinery/Components
    Industrials

    Stanley M. Bergman to Retire as Henry Schein's Chief Executive Officer at the End of 2025

    Mr. Bergman to Continue to Serve as Chairman of the Board Henry Schein, Inc. (NASDAQ:HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that Stanley M. Bergman will retire as Chief Executive Officer (CEO) at the end of the year after 45 years at the Company, including more than 35 years as CEO. Mr. Bergman will continue to lead Henry Schein in his current role until his retirement and will remain as Chairman thereafter. The Board is commencing a formal search process in conjunction with a nationally recognized executive search firm and will consider internal and external candidates. "With the progress made advan

    7/15/25 7:05:00 AM ET
    $HSIC
    Medical Specialities
    Health Care

    $CL
    $HSIC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Henry Schein Inc.

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    11/13/24 3:30:01 PM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Henry Schein Inc.

    SC 13G - HENRY SCHEIN INC (0001000228) (Subject)

    11/12/24 9:32:27 AM ET
    $HSIC
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by Henry Schein Inc. (Amendment)

    SC 13G/A - HENRY SCHEIN INC (0001000228) (Subject)

    2/14/24 11:18:57 AM ET
    $HSIC
    Medical Specialities
    Health Care